Literature DB >> 26629154

Comparison of anti-reflux mechanism between Double-J-Stent and standart Double-J-Stent use for risk of BK nephropathy and urinary tract Infection in kidney transplantation.

Nurettin Ay1, Mehmet Veysi Bahadır2, Melih Anıl3, Vahhac Alp1, Şafak Kaya4, Utkan Sevük5, Mesut Gül2, Ramazan Danış3.   

Abstract

OBJECTIVES: There are studies that show that double J stenting (DJS) increase BK nephropathy (BKN) 4 fold. DJS may cause vesicoureteral reflux (VUR) with normal bladder contraction. The aim of this study is to comparison risk of BKN, urinary tract infections (UTI) and postoperative urologic complications with the use DJS with anti-reflux device (ARD-DJS) and standart double J stent (St-DJS). Matherial and methods: Ninety patients (male/female: 50/40) that had undergone kidney transplantations in Diyarbakır Training and Research Hospital and Dicle University, Faculty of Medicine Hospital between January 2012 and April 2015 were enrolled in the study. Demographic data, immunosuppression protocols, presence of rejection, graft loss, postoperative urologic complications, UTI, plasma BK levels of the patients were evaluated retrospectively.
RESULTS: Median and IQR follow up time for ARD-DJS and St-DJS patients were 14 (12-18) months and 25 (16-30) months respectively. Five cases (5.5%) had BK viremia (P=0.025). All 5 cases with BK viremia were St-DJS users.
CONCLUSION: As a result for postoperative UTI and postoperative urinary complication risk there were no statistically significant difference between ARD-DJS use and St-DJS use during ureteral anastomosis. BKN univariate analysis were significantly less than those st-DJS used. Risc factors were evaluated. But results were not statistically significant in the logistic regression analysis. We think that to demonstrate this benefit, we need randomized controlled studies with more patients and longer follow up.

Entities:  

Keywords:  BK nephropathy; Double J stenting; anti-reflux device

Year:  2015        PMID: 26629154      PMCID: PMC4659042     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Trends in immune function assay (ImmuKnow; Cylex™) results in the first year post-transplant and relationship to BK virus infection.

Authors:  Jane Gralla; Janna Huskey; Alexander C Wiseman
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

Review 2.  Human polyomavirus JC and BK persistent infection.

Authors:  Kristina Doerries
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  BK virus nephropathy in a heart transplant recipient: case report and review of the literature.

Authors:  C E H Barber; T J C Hewlett; L Geldenhuys; B A Kiberd; P D Acott; T F Hatchette
Journal:  Transpl Infect Dis       Date:  2006-06       Impact factor: 2.228

4.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

5.  Use of stenting in living donor kidney transplantation: does it reduce vesicoureteral complications?

Authors:  L F C Dols; T Terkivatan; N F M Kok; T C K Tran; W Weimar; J N M IJzermans; J I Roodnat
Journal:  Transplant Proc       Date:  2011-06       Impact factor: 1.066

6.  Polyomavirus nephropathy in native kidneys of non-renal transplant recipients.

Authors:  Ajit P Limaye; Kelly D Smith; Linda Cook; Debra A Groom; Nicholas C Hunt; Keith R Jerome; Michael Boeckh
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

7.  Routine stenting reduces urologic complications as compared with stenting "on demand" in adult kidney transplantation.

Authors:  Panco Georgiev; Christian Böni; Felix Dahm; Christine F Maurus; Stefan Wildi; Valentin Rousson; Rudolf P Wüthrich; Pierre-Alain Clavien; Markus Weber
Journal:  Urology       Date:  2007-10-24       Impact factor: 2.649

8.  HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients.

Authors:  Yehia Awadalla; Parmjeet Randhawa; Kris Ruppert; Adriana Zeevi; Rene J Duquesnoy
Journal:  Am J Transplant       Date:  2004-10       Impact factor: 8.086

Review 9.  BK virus nephropathy and kidney transplantation.

Authors:  Daniel L Bohl; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

10.  Impact of stents on urological complications and health care expenditure in renal transplant recipients: results of a prospective, randomized clinical trial.

Authors:  A Tavakoli; R S Surange; R C Pearson; N R Parrott; T Augustine; H N Riad
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  1 in total

Review 1.  Early double J stent removal in renal transplant patients to prevent urinary tract infection - systematic review and meta-analysis of randomized controlled trials.

Authors:  Dafna Yahav; Hefziba Green; Noa Eliakim-Raz; Eytan Mor; Shahid Husain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-24       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.